Study

EORTC-2324-QLG-TCG

Long-term quality of life and late toxicity in thyroid cancer survivors (LoQoT)

Study documentation Back to result

Recruiting

Date of activation: 01-Nov-2025

None

QoL Non Module Study Development
Not randomized / N.A.

EORTC Groups: 2320 - All Groups: 2320

None

Laura Locati (Study Coordinator), Istituti Clinici Scientifici Maugeri, Pavia
Susanne Singer (Study Coordinator), Univ. Rostock - Campus Schilingallee, Rostock
Lotte van der Weijst (QoL Specialist), EORTC Headquarters, Brussels

King Hussein Cancer Center (Amman, Jordan)
APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France)
Univ Mainz - Institut fuer Medizinische -Biometrie, Epidemiologie und informatik (Mainz, Germany)
Universita Degli Studi Di Siena -Policlinico "le Scotte" (Siena, Italy)
Centro Di Riferimento Oncologico (Aviano, Italy)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
M. Sklodowka-Curie National Research Institute of Oncology Gliwice Branch (Gliwice, Poland)
Otto-Von-Guericke-Universitaet Magdeburg - Universitaetsklinik (Magdeburg, Germany)
Universitaetsklinikum Giessen und Marburg - Campus Marburg (Marburg, Germany)
Univ. of Florence -Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
Hospital Universitario San Carlos (Madrid, Spain)
Radboud University Medical Center Nijmegen (Nijmegen, Netherlands)
IRCCS - Fondazione G. Pascale (Napoli, Italy)
Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany)
Univ. Rostock - Campus Schilingallee (Rostock, Germany)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Aichi Cancer Center Hospital (Aichi, Japan)
A.Z. St. Jan (Brugge, Belgium)
UMC-Academisch Ziekenhuis Utrecht (Utrecht, Netherlands)
Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France)
Institut Jules Bordet (Anderlecht, Belgium)